Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
POLYMERISATION INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2003/106390
Kind Code:
A1
Abstract:
A polymerisation inhibitor comprising a non-hindered cyclic hydroxylamine either alone or in combination with an additional inhibitor.

Inventors:
PHILIPS EMYR (GB)
LOYNS COLIN (GB)
Application Number:
PCT/GB2003/002367
Publication Date:
December 24, 2003
Filing Date:
May 30, 2003
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
A H MARKS & COMPANY LTD (GB)
PHILIPS EMYR (GB)
LOYNS COLIN (GB)
International Classes:
C07D205/04; C07D207/04; C07D207/20; C07D209/04; C07D209/86; C07D211/94; C07D215/58; C07D225/02; C07D295/027; C07D295/24; C08F2/40; C08K5/3412; C07D295/22; C07D295/02; (IPC1-7): C07C7/20; C07C239/08; C07C239/12; C07C239/16; C07D205/04; C07D207/04; C07D207/20; C07D209/04; C07D209/86; C07D225/02; C07D295/02; C07D295/22; C07D215/06; C07D211/94; C08K5/3435
Domestic Patent References:
WO2000014175A12000-03-16
Foreign References:
US3265751A1966-08-09
US3265752A1966-08-09
US2843481A1958-07-15
US6031130A2000-02-29
EP0512951A11992-11-11
US5446220A1995-08-29
Other References:
DATABASE CAPLUS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; XP002252353, retrieved from CA Database accession no. 1998:643472
DATABASE CAPLUS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; XP002252354, retrieved from CA Database accession no. 1993:255417
DATABASE CAPLUS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; XP002252355, retrieved from CA Database accession no. 1991:164864
DATABASE CAPLUS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; XP002252356, retrieved from CA Database accession no. 1991:164863
DATABASE CAPLUS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; XP002252357, retrieved from CA Database accession no. 1990:217575
DATABASE CAPLUS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; XP002252358, retrieved from CA Database accession no. 1986:627842
DATABASE CROSSFIRE BEILSTEIN [online] Beilstein Institut zur Förderung der Chemischen Wissenschaften, Frankfurt am Main, DE; XP002252345, retrieved from BEILSTEIN Database accession no. 1129
DATABASE CROSSFIRE BEILSTEIN [online] Beilstein Institut zur Förderung der Chemischen Wissenschaften, Frankfurt am Main, DE; XP002252346, retrieved from BEILSTEIN Database accession no. 12432
DATABASE CROSSFIRE BEILSTEIN [online] Beilstein Institut zur Förderung der Chemischen Wissenschaften, Frankfurt am Main, DE; XP002252347, retrieved from BEILSTEIN Database accession no. 1560342
DATABASE CROSSFIRE BEILSTEIN [online] Beilstein Institut zur Förderung der Chemischen Wissenschaften, Frankfurt am Main, DE; XP002252348, retrieved from BEILSTEIN Database accession no. 1421020
Attorney, Agent or Firm:
Browne, Robin Forsythe (Tower House Merrion Way, Leeds LS2 8PA, GB)
Download PDF:
Claims:
CLAIMS
1. A polymerisation inhibitor comprising a nonhindered cyclic hydroxylamine either alone or in combination with an additional inhibitor.
2. A polymerisation inhibitor as claimed in claim 1, wherein the nonhindered cyclic hydroxylamine is cyclic hydroxylamine having no alkyl or other alpha substituents adjacent the hydroxylamine group. Preferred compounds have the formula (1). wherein X is a group selected from: (CH2) mY (CH2) n wherein m and n are each independently an integer from 0 to 5 and Y is a CH2, or a hetero atom eg O, S or NH and wherein one or more CH2 is optionally substituted with one or more ClC5 alkyl groups; (CH2) rCH = CH(CH2) swherein r and s are independently integers from 0 to 3, optionally substituted with one or more ClC5 alkyl groups.
3. A polymerisation inhibitor as claimed in claim 2, wherein they hydroxylamine is selected from the group consisting of : 1hydroxypiperidine, 4hydroxymorpholine, 1hydroxypyrrolidine, 1hydroxyazetidine, 1hydroxy2, 5dihydropyrrole, 1hydroxyhexamethyleneimine, 1hydroxyazocan.
4. A polymerisation inhibitor as claimed in claim 2, wherein the hydroxylamine is selected from the group consisting of partially saturated aromatic bi or tricyclic unhindered hydroxylamines and mixtures thereof.
5. A polymerisation inhibitor as claimed in claim 4, wherein the hydroxylamine is selected from the group consisting of : lhydroxy2, 3,4trihydroquinoline, 9hydroxycarbozole and 1hydroxy2, 3dihydroindole, optionally substituted with one or more ClC5 alkyl groups, and mixtures thereof.
6. A polymerisation inhibitor as claimed in claim 3, wherein the hydroxylamine is selected from the group consisting of : 1hydroxypiperidine, 4 hydroxymorpholine and mixtures thereof.
7. A polymerisation inhibitor as claimed in any preceding claim, wherein the coinhibitor is selected from the group consisting of nitrophenols, substituted nitrophenols and stable freeradicals.
8. A polymerisation inhibitor as claimed in claim 7, wherein the inhibitor is selected from: 2,4dinitrophenol, 2secbutyl4,6dinitrophenyl, 4hydroxy tempo, 4oxo tempo, 4amino tempo, talkylcatechols, talkylhydroxyquinones, benzoquinones, and p phenylene diamines.
9. A polymerisation inhibitor as claimed in claim 7 or 8, wherein the amount of coinhibitor is in the range from a trace to 96% by weight of the total amount of inhibitor.
10. A polymerisation inhibitor as claimed in claim 9, wherein the amount of co inhibitor is 40 to 96% by weight of the total amount of inhibitor.
11. A polymerisation inhibited composition comprising a monomer and an inhibitor as claimed in any preceding claim.
12. A method of inhibiting polymerisation during production, purification, storage or use of a vinyl aolefin, acrylic, conjugated diene or other ethylenically unsaturated monomer comprising the step of addition to the monomer of a polymerisation inhibitor as claimed in any of claims 1 to 10.
Description:
POLYMERISATION INHIBITOR This invention relates to compositions for inhibiting polymerisation of unsaturated monomers, particularly vinyl, a-olefin, acrylic, conjugated diene or other ethylenically unsaturated monomers, and most particularly vinyl aromatic compounds, especially styrene. This invention also relates to a method of inhibiting polymerisation of such monomers.

US 2965685 discloses use of N, N-dialkylhydroxylamines to prevent polymerisation of styrene. Various combinations of N, N-dialkylhydroxylamines with other inhibitors have been disclosed.

According to a first aspect of the present invention there is provided a polymerisation inhibitor comprising a non-hindered cyclic hydroxylamine either alone or in combination with an additional inhibitor.

The non-hindered cyclic hydroxylamine is a cyclic hydroxylamine having no alkyl or other alpha substituents adjacent the hydroxylamine group. Preferred compounds have the formula (1). wherein X is a group selected from: (CH2) mY (CH2) n wherein m and n are each independently an integer from 0 to 5 and Y is a CH2, or a hetero atom eg O, S or NH and wherein one or more CH2 is optionally substituted with one or more CI-C5 alkyl groups; -(CH2) r-CH = CH-(CH2) s-wherein r and s are independently integers from 0 to 3, optionally substituted with one or more Cl-C5 alkyl groups.

Preferred examples include: 1-hydroxypiperidine, 4-hydroxymorpholine, 1-hydroxypyrrolidine, 1-hydroxyazetidine, 1-hydroxy-2, 5-dihydropyrrole, 1-hydroxyhexamethyleneimine, 1-hydroxyazocan. Partially saturated aromatic bi or tricyclic unhindered hydroxylamines may also be employed, for example, selected from: 1-hydroxy-2, 3,4-trihydroquinoline, 9-hydroxycarbozole and 1-hydroxy-2, 3-dihydroindole.

These compounds may be optionally substituted with one or more C,-C5 alkyl groups.

Mixtures of compounds may be employed.

Particularly preferred compounds are selected from : 1-hydroxypiperidine, 4-hydroxymorpholine and mixtures thereof.

The inhibitor in accordance with the first aspect of this invention may be used in combination with one or more co-inhibitors eg nitrophenols such as 2,4-dinitrophenol (DNP) or substituted nitro phenols such as 2-sec-butyl-4, 6-dinitrophenol (DNBP).

Alternative co-inhibitors may be selected from free radicals (SFR's) such as 4-hydroxy TEMPO, 4-oxo TEMPO, and 4-amino TEMPO, t-alkylcatechols, t-alkylhydroquinones, benzoquinones, p-phenylene diamines and other inhibitors known to those skilled in the art.

The amount of co-inhibitor may be in the range from a trace (eg 1%) to 96%, preferably 40 to 96% by weight of the total amount of inhibitor.

Percentages and other proportions referred to in the specification are by weight unless indicated otherwise. Percentages and proportions may be selected from ranges referred to in the specification to total 100%.

According to a second aspect of the present invention a polymerisation inhibited composition comprises a monomer and an inhibitor in accordance with the first aspect of this invention.

According to a third aspect of this invention a method of inhibiting polymerisation during production, purification, storage or use of a vinyl, a-olefin, acrylic, conjugated diene or other ethylenically unsaturated monomer comprises the step of addition to the monomer of a polymerisation inhibitor in accordance with the first aspect of the present invention.

Unhindered cyclic hydroxylamines in accordance with the present invention have been found to be excellent polymerisation inhibitors, particularly of vinyl aromatic compounds, especially at elevated temperatures. 1-hydroxypiperidine and 4-hydroxymorpholine have been found to be particularly effective inhibitors of styrene polymer formation, both on their own and in combination with 2-sec-butyl-4, 6-dinitrophenol (DNBP). Unfavourable premature polymerisation in processing steps such as the production, purification, storage, shipment preparation and use of these monomers or in a mixture of the monomers or a hydrocarbon mixture containing such monomers. Premature polymerisation can cause contamination of the monomer and degradation of the properties of the monomer. A polymer can be deposited in the apparatus. Formation of popcorn polymer is particularly undesirable. The polymerisation inhibitor in accordance with the first aspect of the present invention is effective not only for monomers and mixtures thereof but also for hydrocarbon mixtures and the like containing a small proportion of the monomers.

The invention is further described by means of examples but not in any limitative sense.

Unhindered cyclic hydroxylamines are disclosed in US 2843481 (Polaroid) and may be prepared by oxidation of the corresponding amines with aqueous hydrogen peroxide at less than 20°C.

Structures: 0 0 OH pH OH 1-HP 4-HM 1-hydroxy- pyrrolidine Mw = 101 Mw = 103 Mw = 87

Results (a) Efficacy Evaluation of the efficacy of hydroxylamines was carried out using a continuous stirred tank reactor (CSTR). These mimic the reboiler of a styrene distillation column. The styrene has a residence time of approximately two hours inside the reactor.

Two CSTRs were used to gather this data. For any given temperature the same CSTR was used for all experiments at that temperature.

120°C CSTR-dead volume was 170 ml. With a styrene flow rate of 75ml/hr the steady state was reached in 4.5 hrs (2 flask volumes). Data gathered after this temperature was averaged to give the steady state polymer level.

110° and 100°C CSTR-dead volume was 150 ml. With a styrene flow rate of 75 ml/hr the steady state was reached in 4 hrs. Data gathered after this point were averaged to give the steady state polymer level.

Nitrogen sparging to remove oxygen was at a measured rate of 200 ml/minute in all experiments. Aside from the inhibitors under test the only variable was the inherent variation in the rate of thermal initiation of styrene polymerisation.

Hydroxylamines were tested on their own and in combination with DNBP as shown in Table 1 (below). By way of comparison results are also presented for prior art styrene inhibitor mixtures, namely 4-Hydroxy tempo with DNBP, 4-Oxo tempo with DNBP and dihydroxypropylhydroxylamine (DHPHA) with DNBP. At a test temperature of 120°C the results shown in Table 1 were obtained (polymer results to nearest 50 ppm).

Results within 10% of each other have been ranked as equal.

Table 1-Results at 120°C Total inhibitor is 400 ppm Component 1 Wt % Component 2 Wt % Average Polymer at Rank Steady State (ppm) 1-hop 100 1850 1 DNBP 90 1-HP 10 2500 2= DNBP 90 4-HM (100%) 10 2600 2= DNBP 95.5 4-Oxo Tempo 4.5 2350 2= DNBP 90 4-Hydroxy 10 3200 5= Tempo DNBP 100 3350 5= DNBP 90 DHPHA 10 3450 5= 4-HM (100%) 100 Failed in 3.5 hours 9 Batch tests were also carried out. This was to determine the optimum ratio of DNBP and 4-HM. This was found to be about 7 parts DNBP to about 3 parts 4-HM.

A further continuous test was carried out using this ratio; Table la Component 1 Wt % Component 2 Wt % Average Polymer at Steady State (ppm) DNBP 70 4-HM (100%) 30 1200 A further test employed a mixture of 1-Hydroxypiperidine and 4-Hydroxy Tempo. This mixture showed synergy, the results are shown in Table lb.

Table lb Component 1 Wt % Component 2 Wt % Average Polymer at Steady State (ppm) 1-HP 100 1850 1-HP 90 4-HT 10 450 At 110°C the results shown in Table 2 were obtained. 4-HM technical grade (65%) showed excellent performance as a single inhibitor at this temperature and therefore the 100% active ingredient was not tested.

Table 2-Results at 110°C Total inhibitor is 250 ppm Component 1 Wt % Component 2 Wt % Average Polymer at Rank Steady State (ppm) 1-HP 100 100 1 DNBP 90 4-HM (100%) 10 250 2 4-HM (65%) 100 700 3= DNBP 90 1-HP 10 1100 5 DNBP 90 4-Hydroxy 10 1600 6 Tempo DNBP 90 DHPHA 10 1900 7 DNBP 95.5 4-Oxo Tempo 4.5 2400 9= DNBP 100 2400 9= At 100°C the results shown in Table 3 were obtained. As before, the results were given to the nearest 50 ppm of polymer and results within 10% of each other were classes as equivalent.

Table 3-Results at 100°C Total 100 ppm inhibitor Component 1 Wt % Component 2 Wt % Average Polymer at Rank Steady State (ppm) 1-HP 100 250 1 DNBP 90 4-HM (100%) 10 450 2 DNBP 90 4-Hydroxy 10 750 3 Tempo 4-HM (65%) 100 1000 4 DNBP 90 DHPHA 10 1900 56 DNBP 95.5 4-Oxo Tempo 4.5 2150 67= DNBP 90 1-HP 10 2300 67= DNBP 100 2750 89 DNBP 100 2400 9= 4-Hydroxymorpholine in 3 component systems In this test N-bis- (1, 4-dimethylpentyl)-p-phenylenediamine (PD) was used as a third component. The results are shown in Table 4.

Table 4-Three component mixtures Test Mixture Polymer formed at 120°C Polymer formed at 100°C (ppm) (ppm) DNB/PD/DHPHA 2750 250 DNBP/PD/4-HM 1350 100 4-Hydroxymorpholine is clearly a superior enhancer of the DNBP/PD system than is DHPHA under our test conditions. It was noted that at 120°C this three component system is equivalent in performance to the two component DNBP/4-HM system.